Schwabe Stefan K.f. - Net Worth and Insider Trading

Schwabe Stefan K.f. Net Worth

The estimated net worth of Schwabe Stefan K.f. is at least $81,497 dollars as of 2024-04-19. Schwabe Stefan K.f. is the Executive Vice President & CMO of Supernus Pharmaceuticals Inc and owns about 2,772 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $81,497. Details can be seen in Schwabe Stefan K.f.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Schwabe Stefan K.f. has not made any transactions after 2020-12-21 and currently still holds the listed stock(s).

Transaction Summary of Schwabe Stefan K.f.

To

Schwabe Stefan K.f. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Schwabe Stefan K.f. owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .

Click here to see the complete history of Schwabe Stefan K.f.’s form 4 insider trades.

Insider Ownership Summary of Schwabe Stefan K.f.

Ticker Comapny Transaction Date Type of Owner
SUPN Supernus Pharmaceuticals Inc 2020-12-21 Executive Vice President R&D

Schwabe Stefan K.f. Latest Holdings Summary

Schwabe Stefan K.f. currently owns a total of 1 stock. Schwabe Stefan K.f. owns 2,772 shares of Supernus Pharmaceuticals Inc (SUPN) as of December 21, 2020, with a value of $81,497.

Latest Holdings of Schwabe Stefan K.f.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SUPN Supernus Pharmaceuticals Inc 2020-12-21 2,772 29.40 81,497

Holding Weightings of Schwabe Stefan K.f.


Schwabe Stefan K.f. Form 4 Trading Tracker

According to the SEC Form 4 filings, Schwabe Stefan K.f. has made a total of 2 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 46,347 shares on December 21, 2020, which brought Schwabe Stefan K.f. around $1 Million.

Insider Trading History of Schwabe Stefan K.f.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Schwabe Stefan K.f. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Schwabe Stefan K.f. Ownership Network

Ownership Network List of Schwabe Stefan K.f.

No Data

Ownership Network Relation of Schwabe Stefan K.f.


Schwabe Stefan K.f. Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Schwabe Stefan K.f. is the Executive Vice President R&D of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Schwabe Stefan K.f. made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

Schwabe Stefan K.f. Mailing Address

Above is the net worth, insider trading, and ownership report for Schwabe Stefan K.f.. You might contact Schwabe Stefan K.f. via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.

Discussions on Schwabe Stefan K.f.

No discussions yet.